We exist to deliver transformative medicines that profoundly impact patient lives. Innovation is our guiding principle, driving us to reimagine the journey of drug discovery and ensure that every step we take is toward significant patient benefits. Fueled by the immediate needs of those we serve, we act swiftly and decisively, propelled by a dedication …
In our pursuit of progress, we embrace the certainty of setbacks, turning lessons from each challenge into our growth. Our commitment to integrity demands transparency, the courage to acknowledge our failures, and the resolve to speak the truth, forging an environment where honesty is met with support, not censure. It is through this open exchange …
At our core, we believe that all value stems from people. Our culture is grounded in diversity, fairness and respect for each individual, creating a space where every team member is heard and valued. Leadership in our company is as much about listening and valuing ideas from each individual as it is about guiding. Teamwork …
David Arkowitz brings over 30 years of experience in finance, operations, business development, and commercial leadership within the life sciences and biotech sectors. He is currently the CFO of Alkeus Pharmaceuticals, a privately held late-stage biopharma company focused on preserving sight in individuals with retinal diseases. Before joining Alkeus, Mr. Arkowitz was EVP, CFO, and …
António Parada is the Founder and CEO of FairJourney Biologics, a leading antibody discovery company supporting over 250 global clients. He founded the company in May 2012, and in June 2024, Partners Group acquired a majority stake in FairJourney. Previously, Mr. Parada was General Manager of Instituto de Biologia Molecular e Celular (IBMC) in Porto, …